Surgery

James Howe, MD

Portrait

Co-Director, Neuroendocrine Cancer Clinic
Director, Division of Surgical Oncology and Endocrine Surgery
Medical Director, University of Iowa Tumor Registry
Professor of Surgery  - Surgical Oncology and Endocrine Surgery

Contact Information

Primary Office: 4644 JCP
Iowa City, IA 52242
Primary Office Phone: 319-356-1727

Email: james-howe@uiowa.edu

Education

Champlain Valley Union High School, Hinesberg, VT
5 "O" levels, Bristol Cathedral School, Bristol, England
H.S. Diploma, Champlain Valley Union High School, Hinesberg, VT
A.B., Biology, Dartmouth College, Hanover, NH
MD, University of Vermont College of Medicine

Residency, Junior Assitant Resident, Barnes Hospital, St. Louis, MO
Surgical Internship, Barnes Hospital, St. Louis, MO
Fellowship, Surgical Research Fellow, Washington University, St. Louis, MO
Residency, Senior Assitant Resident, Barnes Hospital, St. Louis, MO
Residency, Fourth Year Resident, Barnes Hospital, St. Louis, MO
Residency, Chief Resident, Barnes Hospital, St. Louis, MO
Fellowship, Clinical, Surgical Oncology, Memorial Sloan-Kettering Center

Licensure & Certifications

Iowa State Medical License
Certified, Advanced Trauma Life Support
Board Certified, American Board of Surgery
Qualifying Examination, American Board of Surgery
Recertification Examination, American Board of Surgery

Research

Work in the Surgical Oncology Molecular Biology lab is focused upon understanding and defining the genetic basis of Juvenile Polyposis (JP). The main objective of our current studies is to identify the third causative gene for this inherited cancer predisposition syndrome. To this end, a large Iowa JP family is being tested using a comprehensive panel of genetic markers derived from all the human chromosomes to determine the chromosomal location of this gene. When candidate genes from this region are found, they will be tested for mutations in this JP family, and a panel of over 90 different JP families. In addition to this research focus, we have also been studying how the mutations in people born with JP lead to the formation of polyps. To do this, we have taken both normal and polyp tissues obtained from surgery or endoscopy in JP patients with mutations in the three different JP genes. From these we have performed microarray analysis, which allows us to compare the level of expression of all human genes. These patterns of changes in gene expression between the different JP genes will help us to understand which genetic pathways are involved in polyp development. We are also systematically examining the effects of the DNA mutations in JP patients upon the RNA messages and protein products that result from them. To do this, we have established cell lines from the white blood cells from a large number of JP patients, which gives us a repository of renewable cells for future studies. This will help to clarify the effects of mutations in some JP patients, while in others in whom no mutations have been found by sequencing, may suggest alterative mechanisms of how the JP genes are inactivated. It will also make in vitro studies possible, which will give us a way to determine the effects of various drugs on cells, so that we may develop treatments that will suppress the development of polyps and cancers.

Selected Publications

Show All

Inhibition of Ubiquitination Restores Protein Levels in Patients Affected with Juvenile Polyposis.  Howe J.  2012  February.

BMPR1A Mutations in Juvenile Polyposis Affect Cellular Localization.  Howe J, Dahdaleh  F, Howe J, Carr J, Wang D.  7th Annual Academic Surgical Congress .  2012  February.

Germline Mutations in SMAD4 Lead to Increased Invasive Potential.  Howe J, Dahdaleh F, Carr J.  7th Annual Academic Surgical Congress .  2012  February.

Inhibition of Ubiquitination Restores Protein Levels in Patients Affected with Juvenile Polyposis.  Howe J, Wang D, Dahdaleh F, Carr  .  7th Annual Academic Surgical Congress.  2012  February.

Sentinel Lymph Node Biopsy for Melanoma: Natural History of 234 Consecutive Patients Treated at a Midwestern Hospital .  Howe J, Liao J, Milhem M, Mezhir J, Hoshi  , Carr J.  Midwestern Melanoma Partnership .  2012  February.

200 Consecutive Adrenalectomies from a Midwestern Institution in the Laparoscopic Era.  Howe J, Carr J, Spanheimer  , Dahdaleh F, Weigel R, Sugg  , Lal  , Liao J.  SSO.  2011  September.

Comparison of Clinicopathologic Factors in 122 Patients with Resected Pancreatic and Ileal Neuroendocrine Tumors from a Single Institution.  Howe J.  2011  September.

The Value of Preoperative Imaging in Ileal Neuroendocrine Tumors.  Howe J, Dahdaleh F, Lorenzen  , Carr  , Liao J, O’Dorisio  .  SSO.  2011  September.

Comparison of Clinicopathologic Factors in 113 Patients with Resected Pancreatic and Ileal Neuroendocrine Tumors from a Single Institution. .  Howe J, O’Dorisio  , Carr  J, Mezhir J, Dahdaleh  F, Liao J, Calva  .  Ann Surg Oncol.  2011; 18 :S24.

Germline mutations in SMAD4 after downstream BMP and TGF-Beta signaling,.  Howe J, Calva  D, Wang,  , Carr  J, Dahdaleh  .  Journal of the American College of Surgeons .  2011; 213 :S27.

Date Last Modified: 01/08/2013 - 17:05:00